Royalty Pharma plc

RPRX
$57.77 (+ $1.99 + 3.57%)
Last updated: 2026-07-04 09:23 UTC
RPRX Metrics
Exchange
🇺🇸 NASDAQ XNGS
Nasdaq/NGS (Global Select Market)United StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINGB00BMVP7Y09
Market Price57.77
Dividend Yield 2.0%
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend 1.0
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyQuarterly
P/E Ratio22.56
EPS1.74
Market Cap$22.9B
Book Value14.95
Price to Book2.625
Beta0.46
52w High41.24
52w Low25.16
Next Earnings DateN/A

Royalty Pharma plc trades under ticker RPRX on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN GB00BMVP7Y09.

About the Company
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
Price History